Genky DrugStores Co., Ltd. (JP:9267) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genky DrugStores Co., Ltd. reports robust financial performance for the fiscal year ended June 20, 2024, with a 9.3% increase in net sales and over 30% growth in operating and ordinary income. The company’s net income attributable to owners of parent also rose significantly by 32.7%, reflecting a strong financial position with an equity ratio of 40.9%. Looking ahead, Genky forecasts continued revenue and net income growth for the next fiscal year, maintaining a positive outlook for investors.
For further insights into JP:9267 stock, check out TipRanks’ Stock Analysis page.